Literature DB >> 31230488

Does serum hemoglobin A1C during early pregnancy predict performance on the 1-hour glucose challenge test?

Miranda Stiewig1, David N Jackson2, David L Howard2.   

Abstract

PURPOSE: To determine the negative and positive predictive values of hemoglobin A1c (HgbA1c) levels in predicting abnormal 1-hour glucose challenge test (GCT) results in pregnancy.
METHODS: This retrospective cohort study consisted of pregnant patients from a private practice obstetrics clinic. The primary exposure was early HgbA1c measurement, and the primary outcome was third trimester 1-hour GCT results above or below 140 mg/dL. We calculated the predictive value of early HgbA1c to identify a 1-hour GCT of ≤140 mg/dL or >140 mg/dL.
RESULTS: Of the 1404 one-hour GCT results, 635 were associated with HgbA1c being measured in a patient on the same day or before the 1-hour GCT. The median interval between the HgbA1c test and the 1-hour GCT was 95 days (IQR 56-122 days). Among women with a hgbA1c less than or equal to 4.9, 5.0 and 5.1, respectively, the probability of their 1 hour GCT being 140 mg/dl or less was 91.3%, 91.0% and 90.1%, respectively (Table 1). Among our study population, 14.5%, 22.8% and 35.0% had an Hgb A1c less than or equal to 4.9, 5.0 and 5.1 respectively. Among women with HgbA1c greater than 6.1, the probability of their 1-hour GCT being greater than 140 mg/dL was 100%. Only 0.3% of our population had HgbA1c greater than 6.1. There was no other cut point for HgbA1c, where the positive predictive value for predicting an abnormal 1-hour GCT was equal to or greater than 90%.
CONCLUSIONS: The greatest value of an early HgbA1C test appears to be that very low values (5.1 or less) can predict a normal 1 h GCT with high probability (at least 90%). However, it has limited ability to predict abnormal 1 h GCT. Overall, an early HgbA1C cannot replace the 1 h GCT based on the current body of evidence.

Entities:  

Keywords:  Gestational diabetes; HgbA1c; glucose challenge test; hemoglobin A1C; positive predictive value

Mesh:

Substances:

Year:  2019        PMID: 31230488     DOI: 10.1080/14767058.2019.1627317

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  1 in total

1.  Early gestational diabetes screening in obese women: a randomized controlled trial.

Authors:  Lorie M Harper; Victoria Jauk; Sherri Longo; Joseph R Biggio; Jeff M Szychowski; Alan T Tita
Journal:  Am J Obstet Gynecol       Date:  2020-01-09       Impact factor: 8.661

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.